Cardinal Health revenue
Cardinal Health's revenue was $254.25bn in fiscal 2026, up 14.2% on the year before. Since fiscal 2010 ($98.50bn) it has grown at a compound 6.1% a year.
Revenue history
| Fiscal year | 2010Jun 2010 | 2011Jun 2011 | 2012Jun 2012 | 2013Jun 2013 | 2014Jun 2014 | 2015Jun 2015 | 2016Jun 2016 | 2017Jun 2017 | 2018Jun 2018 | 2019Jun 2019 | 2020Jun 2020 | 2021Jun 2021 | 2022Jun 2022 | 2023Jun 2023 | 2024Jun 2024 | 2025Jun 2025 | 2026Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 98.5 | 102.6 | 107.6 | 101.1 | 91.1 | 102.5 | 121.5 | 130.0 | 136.8 | 145.5 | 152.9 | 162.5 | 181.3 | 205.0 | 226.8 | 222.6 | 254.2 |
| Growth on the year before | — | +4.2% | +4.8% | −6.0% | −9.9% | +12.6% | +18.5% | +6.9% | +5.3% | +6.4% | +5.1% | +6.2% | +11.6% | +13.0% | +10.7% | −1.9% | +14.2% |
| Gross profit | 3.8 | 4.2 | 4.5 | 4.9 | 5.2 | 5.7 | 6.5 | 6.5 | 7.2 | 6.8 | 6.9 | 6.8 | 6.5 | 6.9 | 7.4 | 8.2 | 9.8 |
| Gross margin | 3.8% | 4.1% | 4.2% | 4.9% | 5.7% | 5.6% | 5.4% | 5.0% | 5.2% | 4.7% | 4.5% | 4.2% | 3.6% | 3.4% | 3.3% | 3.7% | 3.8% |
Where the revenue comes from
| Region | Revenue | Share | YoY |
|---|---|---|---|
| United States | $253B | 99.3% | ▲ 14.3% |
| Outside the US | $1.7B | 0.7% | ▲ 2.2% |
From Cardinal Health's 10-K filed August 11, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Cardinal Health | $244.67bn | 10.1% | 8.2% |
| Cencora | $332.77bn | 5.1% | 9.4% |
| McKesson | $410.98bn | 8.8% | 13.1% |
| Henry Schein | $13.60bn | 6.5% | 2.6% |
| 111, Inc. | $1.75bn | -12.7% | — |
| Cosmos Health Inc. | $73.7m | 33.8% | 14.8% |
Compare with peers
Head to head: CAH vs CORCAH vs MCKCAH vs HSIC
More: Health Care Distributors stocks compared, Health Care sector, rankings of US companies